DE69932597D1 - Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung - Google Patents

Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung

Info

Publication number
DE69932597D1
DE69932597D1 DE69932597T DE69932597T DE69932597D1 DE 69932597 D1 DE69932597 D1 DE 69932597D1 DE 69932597 T DE69932597 T DE 69932597T DE 69932597 T DE69932597 T DE 69932597T DE 69932597 D1 DE69932597 D1 DE 69932597D1
Authority
DE
Germany
Prior art keywords
prpres
suspension
buffer solution
biological sample
ranging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69932597T
Other languages
English (en)
Other versions
DE69932597T2 (de
Inventor
Jean-Philippe Deslys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Commissariat a lEnergie Atomique CEA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat a lEnergie Atomique CEA filed Critical Commissariat a lEnergie Atomique CEA
Publication of DE69932597D1 publication Critical patent/DE69932597D1/de
Application granted granted Critical
Publication of DE69932597T2 publication Critical patent/DE69932597T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Detergent Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)
DE69932597T 1998-02-16 1999-02-16 Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung Expired - Lifetime DE69932597T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9801823A FR2774988B1 (fr) 1998-02-16 1998-02-16 Procede de purification de la prpres a partir d'un echantillon biologique et ses applications
FR9801823 1998-02-16
PCT/FR1999/000338 WO1999041280A1 (fr) 1998-02-16 1999-02-16 PROCEDE DE PURIFICATION DE LA PrPres A PARTIR D'UN ECHANTILLON BIOLOGIQUE ET SES APPLICATIONS

Publications (2)

Publication Number Publication Date
DE69932597D1 true DE69932597D1 (de) 2006-09-14
DE69932597T2 DE69932597T2 (de) 2007-08-02

Family

ID=9522996

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69932597T Expired - Lifetime DE69932597T2 (de) 1998-02-16 1999-02-16 Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung

Country Status (13)

Country Link
US (1) US6780979B1 (de)
EP (1) EP1054897B1 (de)
JP (2) JP3913473B2 (de)
AT (1) ATE335004T1 (de)
AU (1) AU761641B2 (de)
CA (1) CA2319687C (de)
DE (1) DE69932597T2 (de)
DK (1) DK1054897T3 (de)
ES (1) ES2270582T3 (de)
FR (1) FR2774988B1 (de)
NZ (1) NZ506225A (de)
PT (1) PT1054897E (de)
WO (1) WO1999041280A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720355B2 (en) * 1997-02-21 2004-04-13 The Regents Of The University Of California Sodium dodecyl sulfate compositions for inactivating prions
FR2801106B1 (fr) * 1999-11-12 2007-10-05 Commissariat Energie Atomique Procede de diagnostic d'une esst provoquee par une souche d'atnc dans un echantillon biologique et son utilisation dans le diagnostic differentiel des differentes souches d'atnc
WO2001038880A1 (en) * 1999-11-23 2001-05-31 Wallac Oy A method for the determination of transmissible spongiform encephalopathies in mammals
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2842303B1 (fr) * 2002-07-09 2004-09-24 Commissariat Energie Atomique Methode de detection automatisable de la prpres et ses applications
AU2003278364A1 (en) * 2002-11-01 2004-05-25 D-Gen Limited Prion decontamination
WO2005024432A1 (en) * 2003-09-04 2005-03-17 Cedi Diagnostics B.V. Methods and kits for detection of prion diseases
WO2005070968A1 (ja) * 2004-01-21 2005-08-04 Wako Pure Chemical Industries, Ltd. 蛋白質の固定化方法及び定量方法
JP4934021B2 (ja) * 2004-04-05 2012-05-16 アイデックス ラボラトリーズ インコーポレイテッド 伝染性海綿状脳症試験の試薬及び方法
CA2598321A1 (en) * 2005-02-19 2006-08-24 Peoplebio, Inc. Method for differentially detecting multimeric form from monomeric form of multimer-forming polypeptides
ES2534471T3 (es) 2006-10-27 2015-04-23 E.I. Du Pont De Nemours And Company Método para la descontaminación de priones
WO2008076994A2 (en) * 2006-12-18 2008-06-26 Anthera Pharmaceuticals, Inc. METHODS FOR DETECTION AND MEASUREMENT OF SECRETORY PHOSPHOLIPASE A2 LEVELS (sPLA2) IN BIOLOGICAL FLUIDS
JP2009052906A (ja) * 2007-08-23 2009-03-12 Nippon Sekijiyuujishiya 伝達性海綿状脳症に係る異常プリオン蛋白質の検出又は測定方法
JP4362837B2 (ja) * 2007-09-14 2009-11-11 富士レビオ株式会社 病原性プリオン蛋白質の検出方法
JP4459299B2 (ja) * 2008-03-21 2010-04-28 積水メディカル株式会社 可溶性lr11の定量方法
KR101866249B1 (ko) * 2016-11-29 2018-06-12 박순현 생체 조직 투명화용 조성물 및 이를 이용한 생체 조직 투명화 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (de) * 1978-11-24 1982-12-04 Hoffmann La Roche
GB2188322A (en) * 1986-03-26 1987-09-30 Bayer Ag Aprotinin and analogues thereof produced by a recombinant host
FR2758337B1 (fr) * 1997-01-14 1999-03-05 Commissariat Energie Atomique Methode de criblage de substances a action therapeutique dans le traitement des esst comprenant une etape d'isolement de la prpres, a partir de la rate, procede d'isolement de le prpres et ses applications
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein

Also Published As

Publication number Publication date
EP1054897B1 (de) 2006-08-02
JP3913473B2 (ja) 2007-05-09
JP2006321819A (ja) 2006-11-30
ES2270582T3 (es) 2007-04-01
AU761641B2 (en) 2003-06-05
NZ506225A (en) 2003-05-30
CA2319687C (fr) 2011-07-05
ATE335004T1 (de) 2006-08-15
WO1999041280A1 (fr) 1999-08-19
EP1054897A1 (de) 2000-11-29
AU2430099A (en) 1999-08-30
DE69932597T2 (de) 2007-08-02
PT1054897E (pt) 2006-12-29
JP4327187B2 (ja) 2009-09-09
US6780979B1 (en) 2004-08-24
CA2319687A1 (fr) 1999-08-19
FR2774988B1 (fr) 2000-05-05
JP2002503675A (ja) 2002-02-05
DK1054897T3 (da) 2006-12-04
FR2774988A1 (fr) 1999-08-20

Similar Documents

Publication Publication Date Title
DE69932597D1 (de) Verfahren zur reinigung von prpres aus einem biologischen muster und dessen verwendung
ATE253898T1 (de) Verbessertes verfahren zur stabilisierung biologischer substanzen während der trocknung und anschliessender lagerung sowie die entsprechenden zusammensetzungen
DE60216447D1 (de) Vorrichtung und verfahren zur bearbeitung biologischer proben
DE69633940D1 (de) Verfahren zur isolierung von zellen
DE69941701D1 (de) Mutanten von flt3-l und ihre verwendungen
ATE222116T1 (de) Verfahren zur identifizierung und isolierung von einem molekül und von diesem erkannte moleküle
AU6380001A (en) Porous ferro- or ferrimagnetic glass particles for isolating molecules
ATE272110T1 (de) Isolierung von nukleinsäuren
DE59907067D1 (de) Polymer-Werkstoff und Herstellungsverfahren, sowie System und Verfahren zur Materialüberprüfung von Polymer-Werkstoffen und Bauteilen
DE69941044D1 (de) Methoden, Apparat und Computerprogramm zur quantitativen Bestimmung von Nukleinsäurensequenzen in Proben unter Verwendung von Standardkurven und Abschätzungen von Amplifikationsverhältnissen
DE19681560T1 (de) Verfahren zur Herstellung von omega-Aminoalkansäure-Derivaten aus Cycloalkanonen
DE69213207D1 (de) Verfahren zur haaranalyse
EE200100040A (et) Meetod raku fenotüüpi muutva modulaatori identifitseerimiseks ja valmistamiseks, sihtmärkbiomolekulide eraldamiseks ja/või samastamiseks ning meditsiinitoote arendamiseks ja valmistamiseks
WO2001057537A3 (en) Methods for diagnosis of alzheimer's disease
DE60134657D1 (de) Phosphat-fluortenside zur verwendung in kohlendioxid
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
WO2000031262A3 (en) Human neurotensin subtype 2 receptor
WO2000034504A3 (en) Method of protein removal
DE59811148D1 (de) Verfahren zur Herstellung von Methylendi(phenylamin)
ATE332974T1 (de) Il-1/tnf-alpha-activated kinase (itak), und verfahren zu ihrer herstellung und verwendung
CY1108038T1 (el) Παρασκευη βαθμονομων και εφαρμογη αυτων στη ποσοστωση νουκλεοτιδικων αλληλουχιων που ενδιαφερουν
ATE377092T1 (de) Verfahren zur isolierung und charakterisierung potentieller funktionen ausgehend von einer biologischen probe, welche nukleinsäuren enthält
WO2000026634A3 (en) Compositions and methods for screening agents that inhibit mapk mediated anti-apoptotic signals
DE59900667D1 (de) Verfahren zur Herstellung von Kaliummonoethylmalonat
GB2289125A (en) Methods of assaying data-repairing enzymes and their alkylated derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition